NEW YORK, June 17, 2016 /PRNewswire/ --
On Thursday, June 16, 2016, the
NASDAQ Composite ended the trading session at 4,844.92, up 0.21%;
the Dow Jones Industrial Average advanced 0.53% to finish at
17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The
gains were broad based as seven out of nine sectors ended the
session in positive. Stock-Callers.com has initiated coverage on
the following equities: Booz Allen Hamilton Holding Corporation
(NYSE: BAH), Qiagen N.V. (NASDAQ: QGEN), INC Research Holdings Inc.
(NASDAQ: INCR), and Myriad Genetics Inc. (NASDAQ: MYGN). Learn more
about these stocks by accessing their free trade alerts at:
http://stock-callers.com/
Booz Allen Hamilton Holding Corporation provides management and
technology, consulting, and engineering services to governments,
corporations, and not-for-profit organizations in the U.S. and
internationally. The stock finished Thursday's session flat at
$28.71 with a total volume of 457,825
shares traded. Over the last one month and the previous one year,
the Company's shares have advanced 4.90% and 13.13%, respectively.
The stock is trading above its 50-day and 200-day moving averages
by 1.14% and 1.52%, respectively. Booz
Allen Hamilton Holding's stock traded at a PE ratio of 14.63
and has a Relative Strength Index (RSI) of 49.09. Sign up and read
the free notes on BAH at:
http://stock-callers.com/
Qiagen N.V. provides sample to insight solutions that transform
biological samples into valuable molecular insights worldwide. The
stock edged 0.29% lower to close the day at $20.74. The stock recorded a trading volume of
978,853 shares, which was above its three months average volume of
936,950 shares. The stock is trading 6.71% below its 50-day moving
average. Additionally, Qiagen's stock traded at a PE ratio of 40.12
and has an RSI of 32.89. The complimentary notes on QGEN can be
downloaded in PDF format at:
http://stock-callers.com/
On Thursday, shares in Raleigh, North
Carolina headquartered contract research organization, INC
Research Holdings Inc., ended the session 1.57% lower at
$38.36 with a total volume of 567,353
shares traded. Shares of the Company traded at a PE ratio of 20.46.
The stock is trading 15.29% below its 50-day moving average.
Moreover, shares of INC Research Holdings have an RSI of 22.01.
Register for free on Stock-Callers.com and access the latest
research on INCR at:
http://stock-callers.com/
On Thursday, shares in Salt Lake City,
Utah headquartered personalized medicine company, Myriad
Genetics Inc., recorded a trading volume of 1.18 million shares,
which was higher than their three months average volume of 884,730
million shares. The stock ended the day 1.46% higher at
$30.63. Shares of the Company traded
at a PE ratio of 20.68. The stock is trading below its 50-day
moving average by 13.73%. Furthermore, shares of Myriad Genetics
have an RSI of 32.70. Get free access to your trade alert on MYGN
at:
http://stock-callers.com/
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored
reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and
micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
SC has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither SC nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly
at:
Office Address: Clyde Offices, Second Floor, 48 West George Street,
Glasgow, U.K. -G2 1BP
Email: info@stock-callers.com
Phone number: +44 330 808 3765
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA